ACE and Alzheimer disease: Taken with in vitro and in vivo studies that demonstrate that ACE cleaves and clears Aβ in an activity-dependent manner, these findings suggest that individuals carrying polymorphisms that increase ACE protein, and possibly ACE activity, may be better able to clear accumulating Aβ aggregates and are thus at reduced risk for developing AD.